Wajeeh Bajwa

Title: Wajeeh Bajwa: Innovator in Hemoglobin Research

Introduction

Wajeeh Bajwa is a notable inventor based in Canton, MI (US), recognized for his contributions to the field of biotechnology. He holds two patents that focus on the expression of recombinant hemoglobin and its variants in yeast. His work has significant implications for medical applications, particularly in the development of blood substitutes.

Latest Patents

Bajwa's latest patents revolve around the expression of recombinant hemoglobin and hemoglobin variants in yeast. The inventions are directed towards creating a substantially pure mammalian globin chain or heme-binding fragment. They involve recombinant DNA vectors capable of expressing at least one globin chain or a substantially homologous variant in yeast. The methods outlined in the patents allow for the combination of expressed alpha-like and beta-like globin chains with a source of heme to produce hemoglobin or its variants. Additionally, expressed gamma-globin chains can also be combined with heme to generate hemoglobin. The hemoglobin produced through these methods can be utilized in applications requiring a physiological oxygen carrier, such as blood substitute solutions and plasma expanders.

Career Highlights

Wajeeh Bajwa is currently associated with Apex Bioscience, Inc., where he continues to advance his research in hemoglobin expression. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to the development of solutions that address critical medical needs.

Collaborations

Bajwa collaborates with esteemed colleagues, including Joseph De Angelo and Nalini M Motwani, who contribute to his research endeavors and help drive innovation in the field.

Conclusion

Wajeeh Bajwa's work in recombinant hemoglobin research exemplifies the intersection of innovation and biotechnology. His patents not only advance scientific understanding but also hold the potential to transform medical applications.